176 related articles for article (PubMed ID: 19100858)
1. Vav1: a hematopoietic signal transduction molecule involved in human malignancies.
Katzav S
Int J Biochem Cell Biol; 2009 Jun; 41(6):1245-8. PubMed ID: 19100858
[TBL] [Abstract][Full Text] [Related]
2. Flesh and blood: the story of Vav1, a gene that signals in hematopoietic cells but can be transforming in human malignancies.
Katzav S
Cancer Lett; 2007 Oct; 255(2):241-54. PubMed ID: 17590270
[TBL] [Abstract][Full Text] [Related]
3. The haematopoietic specific signal transducer Vav1 is aberrantly expressed in lung cancer and plays a role in tumourigenesis.
Lazer G; Idelchuk Y; Schapira V; Pikarsky E; Katzav S
J Pathol; 2009 Sep; 219(1):25-34. PubMed ID: 19533802
[TBL] [Abstract][Full Text] [Related]
4. The association of Sam68 with Vav1 contributes to tumorigenesis.
Lazer G; Pe'er L; Schapira V; Richard S; Katzav S
Cell Signal; 2007 Dec; 19(12):2479-86. PubMed ID: 17855053
[TBL] [Abstract][Full Text] [Related]
5. Vav: function and regulation in hematopoietic cell signaling.
Bonnefoy-BĂ©rard N; Munshi A; Yron I; Wu S; Collins TL; Deckert M; Shalom-Barak T; Giampa L; Herbert E; Hernandez J; Meller N; Couture C; Altman A
Stem Cells; 1996 May; 14(3):250-68. PubMed ID: 8724692
[TBL] [Abstract][Full Text] [Related]
6. Osteopontin is an oncogenic Vav1- but not wild-type Vav1-responsive gene: implications for fibroblast transformation.
Schapira V; Lazer G; Katzav S
Cancer Res; 2006 Jun; 66(12):6183-91. PubMed ID: 16778192
[TBL] [Abstract][Full Text] [Related]
7. Vav: a potential link between tyrosine kinases and ras-like GTPases in hematopoietic cell signaling.
Hu P; Margolis B; Schlessinger J
Bioessays; 1993 Mar; 15(3):179-83. PubMed ID: 8489524
[TBL] [Abstract][Full Text] [Related]
8. Vav: Captain Hook for signal transduction?
Katzav S
Crit Rev Oncog; 1995; 6(2):87-97. PubMed ID: 8792085
[TBL] [Abstract][Full Text] [Related]
9. Vav1: A Dr. Jekyll and Mr. Hyde protein--good for the hematopoietic system, bad for cancer.
Katzav S
Oncotarget; 2015 Oct; 6(30):28731-42. PubMed ID: 26353933
[TBL] [Abstract][Full Text] [Related]
10. The hematopoietically expressed vav proto-oncogene shares homology with the dbl GDP-GTP exchange factor, the bcr gene and a yeast gene (CDC24) involved in cytoskeletal organization.
Adams JM; Houston H; Allen J; Lints T; Harvey R
Oncogene; 1992 Apr; 7(4):611-8. PubMed ID: 1565462
[TBL] [Abstract][Full Text] [Related]
11. Vav-family proteins in T-cell signalling.
Tybulewicz VL
Curr Opin Immunol; 2005 Jun; 17(3):267-74. PubMed ID: 15886116
[TBL] [Abstract][Full Text] [Related]
12. Oncogenic Vav1 induces Rac-dependent apoptosis via inhibition of Bcl-2 family proteins and collaborates with p53 deficiency to promote hematopoietic progenitor cell proliferation.
Gu Y; Siefring JE; Wang L; Chae HD; Bailey JR; Zheng Y
Oncogene; 2006 Jun; 25(28):3963-72. PubMed ID: 16474842
[TBL] [Abstract][Full Text] [Related]
13. Unraveling the Oncogenic Potential of VAV1 in Human Cancer: Lessons from Mouse Models.
Shalom B; Salaymeh Y; Risling M; Katzav S
Cells; 2023 Apr; 12(9):. PubMed ID: 37174676
[TBL] [Abstract][Full Text] [Related]
14. Distinct functions of Vav1 in JNK1 activation in Jurkat T cells versus non-haematopoietic cells.
Kaminski S; Del Pozo MA; Hipskind RA; Altman A; Villalba M
Scand J Immunol; 2004 Jun; 59(6):527-35. PubMed ID: 15182247
[TBL] [Abstract][Full Text] [Related]
15. The haematopoietic specific signal transducer Vav1 is expressed in a subset of human neuroblastomas.
Hornstein I; Pikarsky E; Groysman M; Amir G; Peylan-Ramu N; Katzav S
J Pathol; 2003 Apr; 199(4):526-33. PubMed ID: 12635144
[TBL] [Abstract][Full Text] [Related]
16. Mutation of Vav1 adaptor region reveals a new oncogenic activation.
Razanadrakoto L; Cormier F; Laurienté V; Dondi E; Gardano L; Katzav S; Guittat L; Varin-Blank N
Oncotarget; 2015 Feb; 6(4):2524-37. PubMed ID: 25426554
[TBL] [Abstract][Full Text] [Related]
17. Acidic region tyrosines provide access points for allosteric activation of the autoinhibited Vav1 Dbl homology domain.
Amarasinghe GK; Rosen MK
Biochemistry; 2005 Nov; 44(46):15257-68. PubMed ID: 16285729
[TBL] [Abstract][Full Text] [Related]
18. Guanine nucleotide exchange factors for RhoGTPases: good therapeutic targets for cancer therapy?
Lazer G; Katzav S
Cell Signal; 2011 Jun; 23(6):969-79. PubMed ID: 21044680
[TBL] [Abstract][Full Text] [Related]
19. Vav1 regulates the migration and adhesion of dendritic cells.
Spurrell DR; Luckashenak NA; Minney DC; Chaplin A; Penninger JM; Liwski RS; Clements JL; West KA
J Immunol; 2009 Jul; 183(1):310-8. PubMed ID: 19542442
[TBL] [Abstract][Full Text] [Related]
20. Tyrosine residues at the carboxyl terminus of Vav1 play an important role in regulation of its biological activity.
Lazer G; Pe'er L; Farago M; Machida K; Mayer BJ; Katzav S
J Biol Chem; 2010 Jul; 285(30):23075-85. PubMed ID: 20457609
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]